Yüklüyor......
CRISPR-Cas13a Inhibits HIV-1 Infection
CRISPR-Cas provides bacteria and archaea with immunity against invading phages and foreign plasmid DNA and has been successfully adapted for gene editing in a variety of species. The class 2 type VI CRISPR-Cas effector Cas13a targets and cleaves RNA, providing protection against RNA phages. Here we...
Kaydedildi:
| Yayımlandı: | Mol Ther Nucleic Acids |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society of Gene & Cell Therapy
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7321785/ https://ncbi.nlm.nih.gov/pubmed/32585623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtn.2020.05.030 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|